Oct. 5, 2023, 9 a.m. | Business Wire

AI – AI-TechPark ai-techpark.com

Appointees Include Two 2024 ACS National Award Recipients, AIML Trailblazer, and Serial Biotech Co-founder. 1859, an AI-driven small molecule drug discovery company advancing next generation medicines, announces the establishment of its Scientific Advisory Board (SAB). Comprising experts in the fields of AI, biotechnology, and chemistry, the board’s achievements span innovative...


The post 1859 announces the Formation of its Scientific Advisory Board first appeared on AI-TechPark.

ai ai data analytics ai information ai learning aiml aitech news ai technology ai technology companies artificial intelligence artificial intelligence chatbot artificial intelligence robot biotech biotechnology chemistry co-founder discovery drug discovery experts fields founder generative artificial intelligence medicines next small

Software Engineer for AI Training Data (School Specific)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Python)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Tier 2)

@ G2i Inc | Remote

Data Engineer

@ Lemon.io | Remote: Europe, LATAM, Canada, UK, Asia, Oceania

Artificial Intelligence – Bioinformatic Expert

@ University of Texas Medical Branch | Galveston, TX

Lead Developer (AI)

@ Cere Network | San Francisco, US